Loading company…
Proteros biostructures GmbH of Germany provides early drug discovery services using protein structural biology and cryo-EM.
Founded in 2000 and based in Germany, Proteros biostructures GmbH provides early drug discovery services for pharmaceutical and biotechnology companies. Its work covers protein structure elucidation, high-resolution protein crystallography and cryo-electron microscopy, with customized binding, kinetics and biochemical assays. In February 2023, Inflexion Private Equity Partners acquired a minority stake in the company from BayBG. It is listed at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in